Yun Su Sim
Overview
Explore the profile of Yun Su Sim including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
67
Citations
549
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Moon S, Choi H, Kang H, Lee S, Sim Y, Park H, et al.
Allergy Asthma Immunol Res
. 2023 Jan;
15(1):83-93.
PMID: 36693360
Purpose: Although the coexistence of asthma and bronchiectasis is common, the impacts of asthma on bronchiectastic patients (BE) have not been well evaluated because this issue using bronchiectasis cohorts has...
12.
Sim Y, Lee J, Lee E, Choi J, Lee C, An T, et al.
J Clin Med
. 2023 Jan;
12(1).
PMID: 36614912
We evaluated whether the pathogens identified during acute exacerbation of chronic obstructive pulmonary disease (AE-COPD) are associated with the COPD medications used in the 6 months before AE-COPD. We collected...
13.
Kim S, Lee H, Joo H, Choi H, Sim Y, Rhee C, et al.
J Korean Med Sci
. 2023 Jan;
38(1):e3.
PMID: 36593687
It is unclear whether young adults with chronic obstructive pulmonary disease (COPD) are at an increased risk of rapid lung function decline. A total of 2,934 Korean adults aged 40-49...
14.
Kim T, Kim S, Choi H, Shin T, Kim H, Jang S, et al.
Cancers (Basel)
. 2022 Oct;
14(19).
PMID: 36230708
The clinical outcomes of patients with lung cancer coexisting with chronic kidney disease (CKD) are reported to have been conflicting. There is insufficient evidence for treatment and prognosis of lung...
15.
Kim C, Ko Y, Moon J, Park Y, Park S, Ban G, et al.
Eur Respir J
. 2022 Sep;
60(4).
PMID: 36104288
No abstract available.
16.
Choi H, Park H, Hyun I, Kim J, Hwang Y, Jang S, et al.
Pharmacoepidemiol Drug Saf
. 2022 Aug;
31(11):1153-1163.
PMID: 35909258
Background: In tuberculosis (TB) treatment, adverse drug reactions (ADRs) can interrupt treatment and decrease the quality of life (QoL). We aimed to prospectively investigate the incidence of ADRs to first-line...
17.
Ahn E, Choi H, Sim Y, Shin T, Kim T
Tuberc Respir Dis (Seoul)
. 2022 Jul;
85(4):361-363.
PMID: 35822319
No abstract available.
18.
Seo H, Sim Y, Min K, Lee J, Kim B, Oh Y, et al.
Int J Chron Obstruct Pulmon Dis
. 2022 Apr;
17:855-867.
PMID: 35480555
Purpose: Data regarding the relationship between microbiologic features and comorbidities in patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) are limited. The aim of this study was to...
19.
Park S, Yoo K, Park Y, Rhee C, Park J, Park H, et al.
Tuberc Respir Dis (Seoul)
. 2021 Nov;
85(1):47-55.
PMID: 34775737
Background: We evaluated the long-term effects of domiciliary noninvasive positive-pressure ventilation (NIPPV) used to treat patients with chronic obstructive pulmonary disease (COPD). Methods: Databases were searched to identify randomized controlled...
20.
Lee H, Sim Y, Jung J, Seo H, Park J, Min K, et al.
Tuberc Respir Dis (Seoul)
. 2021 Oct;
85(1):37-46.
PMID: 34666427
Background: Although respiratory tract infection is one of the most important factors triggering acute exacerbation of chronic obstructive pulmonary disease (AE-COPD), limited data are available to suggest an epidemiologic pattern...